Phase II study of dutasteride in prostate cancer recurrent during androgen deprivation therapy.

Trial Profile

Phase II study of dutasteride in prostate cancer recurrent during androgen deprivation therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 01 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top